Amgen adds new NC plant to the list as part of $1B manufacturing expansion plans stateside
What can $1 billion buy? If you’re Amgen, it’s good for two manufacturing facilities in the US.
The California-based drug giant will invest close to $550 million in a drug substance plant in Holly Springs, NC, adding itself to an ever-growing list of biotech companies that have decided to call North Carolina home, and marking its second drug manufacturing announcement in a little more than a month.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
